Skip to main navigation Skip to search Skip to main content

Reconstructing an ovary cancer microenvironment for in vitro 3D drug testing: A new avenue for ovary cancer research

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To elaborate on in vitro 3D ovary cancer models that can mimic the in vivo condition of an ovary cancer microenvironment for anticancer drug discovery. Methods: Literature research was conducted in NCBI, ScienceDirect, and Pubchem databases. A total of 19 articles relevant to the search terms were included in this review. Results: The ovary cancer niche has been described as the home of cancer stem cells, multipotent stromal cells, fibroblasts, blood and lymphatic vessels, growth factors, extracellular matrix protein (ECM). Cell cancer behaviour toward anticancer drugs can also be altered by deposition of ECM. A human ovary decellularized protocol generates ovary scaffold. Incorporation of cancer stem cells (CSC) in the ovary cancer niche thus yield 3D reconstructed microenvironment for further anticancer drug testing. Conclusion: The 3D reconstructed microenvironment provides a platform for further anticancer drug testing.

Original languageEnglish
Pages (from-to)S129-S133
JournalJournal of the Pakistan Medical Association
Volume71
Issue number2
Publication statusPublished - Feb 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CSC
  • Cancer microenvironment
  • ECM.
  • Ovary cancer
  • Scaffold

Fingerprint

Dive into the research topics of 'Reconstructing an ovary cancer microenvironment for in vitro 3D drug testing: A new avenue for ovary cancer research'. Together they form a unique fingerprint.

Cite this